HK1070646A1 - Neurotensin active 2,3-diaryl-pyrazolidine derivatives - Google Patents

Neurotensin active 2,3-diaryl-pyrazolidine derivatives

Info

Publication number
HK1070646A1
HK1070646A1 HK05103186.3A HK05103186A HK1070646A1 HK 1070646 A1 HK1070646 A1 HK 1070646A1 HK 05103186 A HK05103186 A HK 05103186A HK 1070646 A1 HK1070646 A1 HK 1070646A1
Authority
HK
Hong Kong
Prior art keywords
neurotensin
diaryl
active
pyrazolidine derivatives
pyrazolidine
Prior art date
Application number
HK05103186.3A
Other languages
English (en)
Inventor
Roelof W Feenstra
Josephus H Lange Jm
L Pras-Raves M Maria
Cornelis G Kruse
Herman H Van Stuivenberg
Tinka Tuinstra
Hiskias G Keizer
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of HK1070646A1 publication Critical patent/HK1070646A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/04—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK05103186.3A 2002-03-18 2005-04-14 Neurotensin active 2,3-diaryl-pyrazolidine derivatives HK1070646A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076482 2002-03-18
PCT/EP2003/050064 WO2003078400A1 (en) 2002-03-18 2003-03-17 Neurotensin active 2,3-diaryl-pyrazolidine derivatives

Publications (1)

Publication Number Publication Date
HK1070646A1 true HK1070646A1 (en) 2005-06-24

Family

ID=27838122

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05103186.3A HK1070646A1 (en) 2002-03-18 2005-04-14 Neurotensin active 2,3-diaryl-pyrazolidine derivatives

Country Status (25)

Country Link
US (1) US7186741B2 (ru)
EP (1) EP1487802B1 (ru)
JP (1) JP4484525B2 (ru)
KR (1) KR20040106290A (ru)
CN (1) CN100509788C (ru)
AR (1) AR038967A1 (ru)
AT (1) ATE493390T1 (ru)
AU (1) AU2003219165B2 (ru)
BR (1) BR0306149A (ru)
CA (1) CA2462694C (ru)
DE (1) DE60335525D1 (ru)
DK (1) DK1487802T3 (ru)
ES (1) ES2358894T3 (ru)
HK (1) HK1070646A1 (ru)
HR (1) HRP20040275A2 (ru)
IL (1) IL160944A0 (ru)
MX (1) MXPA04004743A (ru)
NO (1) NO20044405L (ru)
PL (1) PL371440A1 (ru)
PT (1) PT1487802E (ru)
RU (1) RU2304578C2 (ru)
SI (1) SI1487802T1 (ru)
UA (1) UA77775C2 (ru)
WO (1) WO2003078400A1 (ru)
ZA (1) ZA200404741B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1801098A1 (en) 2005-12-16 2007-06-27 Merck Sante 2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
CN102241678B (zh) 2011-04-26 2014-10-29 辽宁利锋科技开发有限公司 含有脂环结构化合物的抗肿瘤作用与应用
AU2015269247B2 (en) 2014-06-06 2019-10-24 Research Triangle Institute Apelin receptor (APJ) agonists and uses thereof
JP2019501899A (ja) 2015-12-09 2019-01-24 リサーチ トライアングル インスティテュート 改良アペリンレセプター（ａｐｊ）アゴニストおよびその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3712365A1 (de) * 1987-04-11 1988-10-27 Hoechst Ag Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
FR2665898B1 (fr) * 1990-08-20 1994-03-11 Sanofi Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2711140B1 (fr) * 1993-10-12 1996-01-05 Sanofi Sa 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
NO20044405L (no) 2004-10-15
PL371440A1 (en) 2005-06-13
ATE493390T1 (de) 2011-01-15
EP1487802A1 (en) 2004-12-22
UA77775C2 (en) 2007-01-15
KR20040106290A (ko) 2004-12-17
CN1592742A (zh) 2005-03-09
JP2005527528A (ja) 2005-09-15
PT1487802E (pt) 2011-03-11
DE60335525D1 (de) 2011-02-10
JP4484525B2 (ja) 2010-06-16
EP1487802B1 (en) 2010-12-29
US20040242493A1 (en) 2004-12-02
DK1487802T3 (da) 2011-04-04
ZA200404741B (en) 2005-08-29
WO2003078400A1 (en) 2003-09-25
SI1487802T1 (sl) 2011-04-29
RU2304578C2 (ru) 2007-08-20
US7186741B2 (en) 2007-03-06
MXPA04004743A (es) 2004-08-02
IL160944A0 (en) 2004-08-31
AU2003219165B2 (en) 2008-03-13
AU2003219165A1 (en) 2003-09-29
CA2462694C (en) 2010-08-10
RU2004114262A (ru) 2005-09-20
HRP20040275A2 (en) 2004-08-31
CN100509788C (zh) 2009-07-08
AR038967A1 (es) 2005-02-02
BR0306149A (pt) 2004-10-19
ES2358894T3 (es) 2011-05-16
CA2462694A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
EG23424A (en) Fungicidal azo-carboxamide derivatives.
SI1555267T1 (sl) 2,3-DIHIDRO-6-NITROIMIDAZO(2,1-b)OKSAZOLI
HK1061852A1 (en) 4,5-dihydro-ih-pyrazole derivatives having cb1-antagonistic activity
AP2005003198A0 (en) Spiroindolinepiperidine derivatives.
ZA200500170B (en) Indole-3-sulphur derivatives.
HK1090368A1 (en) 2,3,6-trisubstituted-4-pyrimidone derivatives
SI2308855T1 (sl) 2,4-diaminopirimidinski derivati
DE60302150D1 (en) N-substituiete heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trion metalloproteinase inhibitoren
ZA200410269B (en) fungicidal active substance combinations.
SI1583763T1 (sl) Benzoazolilpiperazinski derivati, ki imajo VR1 antagonistično delovanje
MXPA03000966A (es) Agentes antidiabeticos.
HK1078568A1 (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
EP1617807A4 (en) SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
IL166730A0 (en) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-Ä1,3,4-oxadiazol-2-ylÜphenyl)pyridine-3-sulphonamide as an anticancer agent
AU2003267210A8 (en) Topical insecticide
HK1070646A1 (en) Neurotensin active 2,3-diaryl-pyrazolidine derivatives
AU2003269949A1 (en) Substituted 1,4-pyrazine derivatives
MXPA03008394A (es) Derivados de biuretano.
AU2003233232A1 (en) Anti-rhinovirus active agents
AU2003223100A8 (en) 1,2,4-triazol-1-yl-propan-2-ol derivatives as anti-fungal agents
AU2003255737A8 (en) Antimicrobial 2, 4-diamino-pteridine derivatives
ZA200201853B (en) Homogeniser.
AU2003285548A1 (en) Insecticidal agent
TJ432B (en) S(7-methyl-5-oxo-5h-1,3,4-thiadi-zoloÄ3,2-aÜpyrimidine-2-yl)-isotiuron gydrobromide le possesesed ofantibakterial activity
EG23305A (en) Preparation of 1,2-dicloroethane.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130317